Merlion Pharms Gmbh Company Profile
✉ Email this page to a colleague
What is the competitive landscape for MERLION PHARMS GMBH, and when can generic versions of MERLION PHARMS GMBH drugs launch?
MERLION PHARMS GMBH has one approved drug.
There are four US patents protecting MERLION PHARMS GMBH drugs.
There are forty-two patent family members on MERLION PHARMS GMBH drugs in eighteen countries.
Summary for Merlion Pharms Gmbh
| International Patents: | 42 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Merlion Pharms Gmbh
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | DISCN | Yes | No | 9,504,691 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | DISCN | Yes | No | 9,993,483 | See Plans and Pricing | Y | See Plans and Pricing | |||
| Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | DISCN | Yes | No | 9,119,859 | See Plans and Pricing | See Plans and Pricing | ||||
| Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | DISCN | Yes | No | 8,536,167 | See Plans and Pricing | See Plans and Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Merlion Pharms Gmbh
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | 6,133,260 | See Plans and Pricing |
| Merlion Pharms Gmbh | XTORO | finafloxacin | SUSPENSION/DROPS;OTIC | 206307-001 | Dec 17, 2014 | 6,432,948 | See Plans and Pricing |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Merlion Pharms Gmbh Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 2448587 | See Plans and Pricing |
| Japan | 2015134827 | See Plans and Pricing |
| China | 109908081 | See Plans and Pricing |
| Argentina | 093813 | See Plans and Pricing |
| Russian Federation | 2570731 | See Plans and Pricing |
| Canada | 2888641 | See Plans and Pricing |
| Japan | 2012532115 | See Plans and Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
